Literature DB >> 23340182

Expanding roles of ABCG1 and sterol transport.

Elizabeth J Tarling1.   

Abstract

PURPOSE OF REVIEW: To offer a comprehensive review on the role of ABCG1 in cellular sterol homeostasis. RECENT
FINDINGS: Early studies with Abcg1 mice indicated that ABCG1 was crucial for tissue lipid homeostasis, especially in the lung. More recent studies have demonstrated that loss of ABCG1 has wide-ranging consequences and impacts lymphocyte and stem cell proliferation, endothelial cell function, macrophage foam cell formation, as well as insulin secretion from pancreatic β cells. Recent studies have also demonstrated that ABCG1 functions as an intracellular lipid transporter, localizes to intracellular vesicles/endosomes, and that the transmembrane domains are sufficient for localization and transport function.
SUMMARY: ABCG1 plays a crucial role in maintaining intracellular sterol and lipid homeostasis. Loss of this transporter has significant, cell-type-specific consequences ranging from effects on cellular proliferation, to surfactant production and/or insulin secretion. Elucidation of the mechanisms by which ABCG1 affects intracellular sterol flux/movement should provide important information that may link ABCG1 to diseases of dysregulated tissue lipid homeostasis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23340182     DOI: 10.1097/MOL.0b013e32835da122

Source DB:  PubMed          Journal:  Curr Opin Lipidol        ISSN: 0957-9672            Impact factor:   4.776


  13 in total

1.  Novel epigenetic determinants of type 2 diabetes in Mexican-American families.

Authors:  Hemant Kulkarni; Mark Z Kos; Jennifer Neary; Thomas D Dyer; Jack W Kent; Harald H H Göring; Shelley A Cole; Anthony G Comuzzie; Laura Almasy; Michael C Mahaney; Joanne E Curran; John Blangero; Melanie A Carless
Journal:  Hum Mol Genet       Date:  2015-06-22       Impact factor: 6.150

2.  ABCG1 is required for pulmonary B-1 B cell and natural antibody homeostasis.

Authors:  Angel Baldan; Ayelet Gonen; Christina Choung; Xuchu Que; Tyler J Marquart; Irene Hernandez; Ingemar Bjorkhem; David A Ford; Joseph L Witztum; Elizabeth J Tarling
Journal:  J Immunol       Date:  2014-10-22       Impact factor: 5.422

Review 3.  Role of ABC transporters in lipid transport and human disease.

Authors:  Elizabeth J Tarling; Thomas Q de Aguiar Vallim; Peter A Edwards
Journal:  Trends Endocrinol Metab       Date:  2013-02-14       Impact factor: 12.015

4.  ABCG1 regulates mouse adipose tissue macrophage cholesterol levels and ratio of M1 to M2 cells in obesity and caloric restriction.

Authors:  Hao Wei; Elizabeth J Tarling; Timothy S McMillen; Chongren Tang; Renée C LeBoeuf
Journal:  J Lipid Res       Date:  2015-10-21       Impact factor: 5.922

5.  AIBP augments cholesterol efflux from alveolar macrophages to surfactant and reduces acute lung inflammation.

Authors:  Soo-Ho Choi; Aaron M Wallace; Dina A Schneider; Elianne Burg; Jungsu Kim; Elena Alekseeva; Niki Dj Ubags; Carlyne D Cool; Longhou Fang; Benjamin T Suratt; Yury I Miller
Journal:  JCI Insight       Date:  2018-08-23

6.  Hepatic Mttp deletion reverses gallstone susceptibility in L-Fabp knockout mice.

Authors:  Yan Xie; Ho Yee Joyce Fung; Elizabeth P Newberry; Susan Kennedy; Jianyang Luo; Rosanne M Crooke; Mark J Graham; Nicholas O Davidson
Journal:  J Lipid Res       Date:  2014-01-28       Impact factor: 5.922

7.  Epigenome-wide association of DNA methylation markers in peripheral blood from Indian Asians and Europeans with incident type 2 diabetes: a nested case-control study.

Authors:  John C Chambers; Marie Loh; Benjamin Lehne; Alexander Drong; Jennifer Kriebel; Valeria Motta; Marjo-Riitta Jarvelin; James Scott; Harald Grallert; Valentina Bollati; Paul Elliott; Mark I McCarthy; Jaspal S Kooner; Simone Wahl; Hannah R Elliott; Federica Rota; William R Scott; Weihua Zhang; Sian-Tsung Tan; Gianluca Campanella; Marc Chadeau-Hyam; Loic Yengo; Rebecca C Richmond; Martyna Adamowicz-Brice; Uzma Afzal; Kiymet Bozaoglu; Zuan Yu Mok; Hong Kiat Ng; François Pattou; Holger Prokisch; Michelle Ann Rozario; Letizia Tarantini; James Abbott; Mika Ala-Korpela; Benedetta Albetti; Ole Ammerpohl; Pier Alberto Bertazzi; Christine Blancher; Robert Caiazzo; John Danesh; Tom R Gaunt; Simon de Lusignan; Christian Gieger; Thomas Illig; Sujeet Jha; Simon Jones; Jeremy Jowett; Antti J Kangas; Anuradhani Kasturiratne; Norihiro Kato; Navaratnam Kotea; Sudhir Kowlessur; Janne Pitkäniemi; Prakash Punjabi; Danish Saleheen; Clemens Schafmayer; Pasi Soininen; E-Shyong Tai; Barbara Thorand; Jaakko Tuomilehto; Ananda Rajitha Wickremasinghe; Soterios A Kyrtopoulos; Timothy J Aitman; Christian Herder; Jochen Hampe; Stéphane Cauchi; Caroline L Relton; Philippe Froguel; Richie Soong; Paolo Vineis
Journal:  Lancet Diabetes Endocrinol       Date:  2015-06-18       Impact factor: 32.069

Review 8.  Non-clinical development of CER-001.

Authors:  Ronald Barbaras
Journal:  Front Pharmacol       Date:  2015-10-06       Impact factor: 5.810

9.  HDL and CER-001 Inverse-Dose Dependent Inhibition of Atherosclerotic Plaque Formation in apoE-/- Mice: Evidence of ABCA1 Down-Regulation.

Authors:  Claudine Tardy; Marine Goffinet; Nadia Boubekeur; Guy Cholez; Rose Ackermann; Gavin Sy; Constance Keyserling; Narendra Lalwani; John F Paolini; Jean-Louis Dasseux; Ronald Barbaras; Rudi Baron
Journal:  PLoS One       Date:  2015-09-03       Impact factor: 3.240

10.  ABCG1 rs57137919G>a polymorphism is functionally associated with varying gene expression and apoptosis of macrophages.

Authors:  Fang Liu; Wei Wang; Yan Xu; Yu Wang; Lian-Feng Chen; Quan Fang; Xiao-Wei Yan
Journal:  PLoS One       Date:  2014-06-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.